Navigation Links
Dendreon Reports Fourth Quarter and 2007 Year End Financial Results
Date:3/13/2008

- Dendreon to Hold Conference Call Today, March 13, 2008 at 11:00 AM ET -

SEATTLE, March 13 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today reported results for the year and quarter ended December 31, 2007. Revenues for the year ended December 31, 2007 were $743,000 compared to $273,000 for the year ended December 31, 2006. Revenues for the fourth quarter of 2007 were $28,000, compared to $86,000 for the same period in 2006.

The net loss for the year ended December 31, 2007 was $99.3 million, or $1.20 per share, compared to $91.6 million, or $1.27 per share for the year ended December 31, 2006. Net loss in the fourth quarter of 2007 was $27.0 million or $0.32 per share, compared to a net loss of $21.5 million, or $0.28 per share, for the same period in 2006. Dendreon's total operating expenses for the year ended December 31, 2007 were $102.4 million compared to $97.6 million in 2006. Net cash used in operating activities in 2007 was $82.6 million compared to $80.8 million in 2006.

As of December 31, 2007, Dendreon had approximately $120.6 million in cash, cash equivalents, and short-term and long-term investments compared to $121.3 million as of December 31, 2006.

Recent Highlights:

-- The FDA agreed to amend the IMPACT (IMmunotherapy for Prostate

AdenoCarcinoma Treatment) Special Protocol Assessment (SPA),

accelerating the expected timeline for final results from the study by

approximately one year while maintaining comparable power to the

previous SPA. In addition, the FDA reconfirmed that either a positive

interim or final analysis of survival would support licensure and

enable Dendreon to amend the company's biologic
'/>"/>

SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Announces Webcast Presentation at UBS Life Sciences Conference
3. Dendreon Secures $130 Million Committed Equity Financing Facility
4. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
5. Dendreon Reports Third Quarter 2007 Financial Results
6. Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer
7. Dendreon Announces Webcast Presentation at BIO CEO & Investor Conference
8. Dendreon Publishes Manuscript on CD54 as a Surrogate Marker of Antigen Presenting Cell Activation
9. -Dendreon to Hold Conference Call on Thursday, March 13, 2008 at 11:00 AM ET-
10. FDA Agrees to Amend Dendreons Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... OHAUS Corporation, a leading worldwide ... and scales, proudly announces its Explorer line of ... magazine’s 2014 “Readers' Choice” Award for best ... Explorer was voted the best laboratory balance by ... celebrates “excellence in product design and performance for ...
(Date:7/22/2014)... SHENZHEN, China , 22 juli 2014 /PRNewswire/ ... dochtermaatschappij van BGI, ,s wereld grootste organisatie op het ... een nieuwe service ten behoeve van hele menselijke genoomsequentie ... Complete Genomics. In 2013 acquireerde BGI ... hoog aanzien staat vanwege de in eigen beheer ontwikkelde ...
(Date:7/22/2014)... 22, 2014  Semler Scientific, Inc. (Nasdaq: ... assessment company that develops patented products that assist ... diseases, today announced that it will report second ... U.S. financial markets on July 25, 2014. Doug Murphy-Chutorian, M.D., ... conference call at 11 a.m. EDT, July 25, 2014. ...
(Date:7/22/2014)... Angeles, CA (PRWEB) July 22, 2014 ... test solutions with the debut of its fluorescent ... of Clinical Chemistry (AACC) meeting in Chicago, July ... or bench top versions, the HRDR-300 is a ... pending technology to analyze fluorescent lateral flow immunoassays ...
Breaking Biology Technology:OHAUS Explorer Voted “Best Balance” in Laboratory Equipment’s 2014 Readers’ Choice Awards 2BGI Tech introduceert service op gebied van hele menselijke exoomsequencing op geavanceerd Complete Genomics-platform 2Semler to Report Second Quarter 2014 Financial Results and Host Conference Call on July 25, 2014 2Holomic to Debut HRDR-300 Fluorescent Immunoassay Reader at the AACC 2014 2
... (NYSE: DGX ), the leading provider of diagnostic ... shareholders,on Friday, May 16th at 10:30 am ET., ... Relations,section of the company Web site at http://www.questdiagnostics.com/investor ... broadcast, a replay will be available on,the Web site ...
... study supports the potential for QLT,s drug elution technology ... reduce and ... QLT Inc. (NASDAQ: QLTI; TSX:,QLT) announced today results from ... QLT Plug Delivery, Inc., of its punctal plug,drug delivery ...
... 12 Amylin Pharmaceuticals,Inc. (Nasdaq: AMLN ) will ... May 14, 2008 at 3:05 p.m. CT / 1:05 ... Finance and Chief Financial Officer of,Amylin Pharmaceuticals, will be ... breakout session will be webcast, and a,recording will be ...
Cached Biology Technology:QLT reports initial proof of concept data for punctal plug delivery technology 2QLT reports initial proof of concept data for punctal plug delivery technology 3QLT reports initial proof of concept data for punctal plug delivery technology 4
(Date:7/22/2014)... feature natural habitats and trees and not just asphalt ... to a University of Colorado Boulder study. , Working ... provide stress-reducing benefits for youth, according to a paper ... The study is one of the first of its ... to green settings and stress. , "Many schools already ...
(Date:7/22/2014)... Conn. , July 22, 2014 ... the growing m-commerce market, announces its next generation smart ... 30-minute consumer oriented television show that airs on ... NewsWatch regularly features top technology ... July 31st on the History Channel (6:00-6:30am ET/PT) ...
(Date:7/21/2014)... researchers have detected genetic fragments of Middle East Respiratory ... holding a camel infected with the virus. The work, ... open-access journal of the American Society for Microbiology, indicates ... disease can be transmitted through the air. , MERS, ... has been identified in 699 people as of June ...
Breaking Biology News(10 mins):Natural-terrain schoolyards reduce children's stress, says Colorado University-Boulder study 2Natural-terrain schoolyards reduce children's stress, says Colorado University-Boulder study 3NXT-ID's Next Generation Wocket Smart Wallet to be Featured on NewsWatch, Airing on History Channel, FYI Network and ION Network 2NXT-ID's Next Generation Wocket Smart Wallet to be Featured on NewsWatch, Airing on History Channel, FYI Network and ION Network 3Middle East Respiratory Syndrome coronavirus detected in the air of a Saudi Arabian camel barn 2
... between tiny single-celled algae and highly specialized bacteria. Their ... the oceans by taking nitrogen from the atmosphere and ... use. Details of the symbiosis, published in ... from the investigation of a mysterious nitrogen-fixing microbe with ...
... Just as women are advised to get plenty of folic ... new research suggests another very similar nutrient may one day ... Consuming greater amounts of choline ... may lower an infant,s vulnerability to stress-related illnesses, such as ...
... Bethesda, MD FASEB MARC (Minority Access to Research ... the 2012 Biomedical Engineering Society (BMES) Annual Meeting in ... meant to promote the entry of underrepresented minority students, ... science community and to encourage the participation of young ...
Cached Biology News:Unusual symbiosis discovered in marine microorganisms 2Unusual symbiosis discovered in marine microorganisms 3Unusual symbiosis discovered in marine microorganisms 4Nutrient in eggs and meat may influence gene expression from infancy to adulthood 2Nutrient in eggs and meat may influence gene expression from infancy to adulthood 3